EUVIMEDEUVIMED entdecken
Crossref

Tumor budding is an optimal indictor of occult cervical metastasis in clinical early‐stage buccal mucosa squamous cell carcinoma

Zhi Zheng, Huan-Xing Yang, Yi-Hong Fang, Jin Wang, Shi-Wei Fu, Qi-Ming Ouyang

Journal of Oral Pathology & Medicine · 2024

DOI: 10.1111/jop.13533 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Oral Pathology & Medicine, 2024. Verfasst von Zhi Zheng und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillofacial Surgery, Fujian Medical University Union Hospital, Fuzhou, China. Hauptthemen laut MEDLINE: Carcinoma, Squamous Cell, Mouth Mucosa, Neoplasm Invasiveness. Die Arbeit nennt 27 Literaturangaben. Gefördert von: Natural Science Foundation of Fujian Province, China, Natural Science Foundation of Fujian Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Buccal mucosa squamous cell carcinoma (BMSCC) is an aggressive disease. This study investigated the clinicopathological significance of tumor budding (TB), depth of invasion (DOI), and mode of invasion (MOI) on occult cervical metastasis (CM) of BMSCC.

Methods

Seventy‐one cT 1–2 N 0 BMSCC patients were included in this retrospective study. TB, DOI, MOI, and other clinicopathological features were reviewed. Risk factors for occult CM, locoregional recurrence‐free survival (LRRFS), and overall survival (OS) were analyzed using logistic regression and Cox's proportional hazard models, respectively.

Results

Multivariate analysis with the logistic regression model revealed that MOI, DOI, and TB were significantly associated with occult CM in early‐stage BMSCC after adjusting for variates. However, multivariate analysis with the Cox's proportional hazard model found only TB to be a prognostic factor for LRRFS (hazard ratio 15.03, 95% confidence interval [CI] 1.94–116.66; p = 0.01; trend test p = 0.03). No significant association was found between MOI, DOI, or TB and OS.

Conclusions

The optimal predictor of occult CM and prognosis of early‐stage BMSCC is TB, which may assist clinicians in identifying patients at high risk of cervical metastasis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Squamous CellMouth MucosaNeoplasm InvasivenessHumansFemaleMaleMiddle AgedRetrospective StudiesAgedAdultMouth NeoplasmsNeoplasm StagingAged, 80 and overRisk FactorsProportional Hazards ModelsPrognosisLymphatic Metastasis

Stichwörter der Autor:innen

buccal mucosa squamous cell carcinomacervical metastasismultivariate analysispredict factortumor budding

Autor:innen und Institutionen

  • Department of Oral and Maxillofacial Surgery, Fujian Medical University Union Hospital, Fuzhou, China.
  • Department of Pathology, Fujian Medical University Union Hospital, Fuzhou, China.

Förderung

  • Natural Science Foundation of Fujian Province, China
  • Natural Science Foundation of Fujian Province

Zitieren

APA

Zheng, Z., Yang, H. X., Fang, Y. H., Wang, J., Fu, S. W., & Ouyang, Q. M. (2024). Tumor budding is an optimal indictor of occult cervical metastasis in clinical early‐stage buccal mucosa squamous cell carcinoma. Journal of Oral Pathology & Medicine. https://doi.org/10.1111/jop.13533

Vancouver

Zheng Z, Yang HX, Fang YH, Wang J, Fu SW, Ouyang QM. Tumor budding is an optimal indictor of occult cervical metastasis in clinical early‐stage buccal mucosa squamous cell carcinoma. Journal of Oral Pathology & Medicine. 2024. doi:10.1111/jop.13533

BibTeX
@article{Zheng2024,
  author = {Zheng, Zhi and Yang, Huan-Xing and Fang, Yi-Hong and Wang, Jin and Fu, Shi-Wei and Ouyang, Qi-Ming},
  title = {Tumor budding is an optimal indictor of occult cervical metastasis in clinical early‐stage buccal mucosa squamous cell carcinoma},
  journal = {Journal of Oral Pathology & Medicine},
  year = {2024},
  doi = {10.1111/jop.13533}
}
Kostenlos starten →